Stay updated on ORION-01 Oregovomab & Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.

Latest updates to the ORION-01 Oregovomab & Nivolumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a minor metadata update to the page. It appears to be a versioning change rather than a substantive content update.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page footer revision tag was updated from v3.6.2 to v3.6.3, indicating a new build of the page. This update does not affect the study details presented.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0. This is a minor frontend/version update and does not change the study details or eligibility information.SummaryDifference0.1%

- Check53 days agoChange DetectedRecruitment status updated to indicate that the study is not looking for participants anymore. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was adjusted, with a site revision tag updated to v3.6.0.SummaryDifference0.5%

- Check60 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This indicates a minor version update to the page without altering the displayed study details.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new build of the site. This change does not modify the study content or public-facing text.SummaryDifference0.1%

Stay in the know with updates to ORION-01 Oregovomab & Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORION-01 Oregovomab & Nivolumab Clinical Trial page.